Veterans-For-Change.org

VFC Visitors Counter

004737331
TodayToday2467
YesterdayYesterday2795
This WeekThis Week5262
This MonthThis Month42890
All DaysAll Days4737331
Highest 06-21-2016 : 17814
IP: 18.206.175.155
Logged In Users 0
Guests 45
Registered Users 1846
Registered Today 0

Latest News

VA News

Agent Blue - Arsenic-Laced Rainbow

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Agent Blue

 

Agent Blue. Agent Orange. Agents Pink, Green, White, and Purple. The Rainbow Agents. Usually, they are all listed under “Agent Orange.” Each agent causes varying degrees of harm to living creatures, from plants to birds to humans. Agent Orange and most of the Rainbow Agents were phenoxy herbicides contaminated with dioxin.

The VA Hospital In DC Was Reportedly Using Rusty Surgical Tools And Water Full Of Bacteria

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Rusty Surgical Tools

 

The persistence of serious problems endangering America’s Veterans at the Department of Veterans Affairs Medical Center in Washington, DC has employees begging Secretary of Veterans Affairs Robert Wilkie for assistance.

New VA secretary warns Trump's signature program could collapse without fix

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Robert Wilkie 08

 

President Trump’s newly installed Veterans Affairs secretary, in his first interview since taking office earlier this week, sounded the alarm about the need to fix a critical program allowing Veterans to see local private doctors instead of driving long distances to a VA hospital.

FDA approves first treatment for rare adrenal tumors

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Adrenal Tumors

 

The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy. This is the first FDA-approved drug for this use.

Copyright © 2016. All Rights Reserved.